Previous Page  5 / 6 Next Page
Information
Show Menu
Previous Page 5 / 6 Next Page
Page Background

allied

academies

Page 24

J Parasit Dis Diagn Ther 2017

Volume 2 Issue 3

September 7-8, 2017 | Edinburgh, Scotland

4

th

International Conference on

Tropical Medicine, Infectious Diseases & Public Health

Notes:

Tropical Medicine 2017

Ranjan Ramasamy, J Parasit Dis Diagn Ther 2017

FLUORESCENCE IN SITU

HYBRIDIZATION (FISH) ASSAYS FOR

DIAGNOSING MALARIA IN ENDEMIC

AREAS

M

alaria is a responsible for approximately 600 thousand

deaths worldwide every year. Appropriate and timely

treatment of malaria can prevent deaths but is dependent

on accurate and rapid diagnosis of the infection. Currently,

microscopic examination of the Giemsa stained blood smears

is the method of choice for diagnosing malaria. Although it

has limited sensitivity and specificity in field conditions, it

still remains the gold standard for the diagnosis of malaria.

Here, we report the development of a fluorescence in situ

hybridization (FISH) based method for detecting malaria

infection in blood smears and describe the use of an LED light

source that makes the method suitable for use in resource-

limited malaria endemic countries. The

Plasmodium

Genus

(P-Genus) FISH assay has a

Plasmodium

genus specific probe

that detects all five species of

Plasmodium

known to cause the

disease in humans. The P. falciparum (PF) FISH assay and

P. vivax (PV) FISH assay detect and differentiate between P.

falciparum and P. vivax respectively from other

Plasmodium

species. The FISH assays are more sensitive than Giemsa.

The sensitivities of P-Genus, PF and PV FISH assays were

found to be 98.2%, 94.5% and 98.3%, respectively compared

to 89.9%, 83.3% and 87.9% for the detection of

Plasmodium

,

P. falciparum and P. vivax by Giemsa staining respectively.

Biography

Ranjan Ramasamy graduated from the University of Cambridge, UK and then obtained

a PhD also from the University of Cambridge. He has since held academic appoint-

ments in the UK and abroad including Australia, Sri Lanka and the USA. He was the

Chairman of the National Science Foundation of Sri Lanka, Professor of Life Sciences

at the Institute of Fundamental Studies in Kandy in Sri Lanka, Professor of Biochemistry

in the University of Jaffna in Jaffna Sri Lanka, Professor of Immunology in the University

Brunei Darussalam Medical School and held institute/ university appointments at the

Scripps Clinic and Research Foundation in La Jolla in the USA, University of Nairobi in

Kenya, King Faisal University in Dammam in Saudi Arabia, the Queensland Institute

of Medical Research in Australia, Anglia Ruskin University in England and the London

School of Hygiene and Tropical Medicine in England. He has more than 200 publica-

tions in fields pertaining to Medical Sciences.

rjr200911@yahoo.com

Ranjan Ramasamy

ID-FISH Technology Incorporation, USA